Related Experiment Video
Updated: Jul 23, 2025

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
Published on: April 13, 2018
MiR-128-3p promotes the progression of deep venous thrombosis through binding SIRT1
Jinan Han1, Wanjiang Hao2, Yanping Ma3
1Department of Vascular Surgery, Hulunbuir People's Hospital, Hulunbuir, China.
Objectives:
This research aimed to study the effect of microRNA-128-3p (miR-128-3p) on deep venous thrombosis (DVT).
Method:
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, Transwell chamber method, and flow cytometry technique were used in the cell experiments. Potential interconnection between miR-128-3p and silent information regulator sirtuin 1 (SIRT1) was revealed by luciferase activity. The concentration of miR-128-3p and mRNA SIRT1 was assessed by quantitative reverse transcription polymerase chain reaction (qRT-PCR). The receiver operating characteristic (ROC) curve was used to test the predictive effect of miR-128-3p in DVT.
Results:
Decreased miR-128-3p expression was beneficial to cell proliferation and migration and inhibited inflammation, apoptosis, and adhesion of human umbilical vein endothelial cells (HUVECs). The impacts of miR-128-3p on HUVECs were achieved by targeting SIRT1. MiR-128-3p was upregulated in patients with DVT, and it was of great significance in differentiating patients with DVT.
Conclusion:
Overexpression of miR-128-3p might become a biomarker for patients with DVT.
Insights
MicroRNA-128-3p (miR-128-3p) impacts deep venous thrombosis (DVT) by targeting SIRT1. Upregulated miR-128-3p in DVT patients suggests its potential as a diagnostic biomarker.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Biomarker Discovery
Background:
- Deep venous thrombosis (DVT) is a significant vascular condition.
- Understanding the molecular mechanisms underlying DVT is crucial for diagnosis and treatment.
- MicroRNAs play regulatory roles in various cellular processes relevant to thrombosis.
Purpose of the Study:
- To investigate the role of microRNA-128-3p (miR-128-3p) in the pathogenesis of deep venous thrombosis (DVT).
- To explore the relationship between miR-128-3p and its potential target, silent information regulator sirtuin 1 (SIRT1).
- To evaluate the diagnostic potential of miR-128-3p in DVT patients.
Main Methods:
- Cellular assays including MTT, Transwell, and flow cytometry were employed.
- Luciferase activity assays identified the interaction between miR-128-3p and SIRT1.
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) measured miR-128-3p and SIRT1 mRNA levels.
- Receiver operating characteristic (ROC) curve analysis assessed the predictive value of miR-128-3p in DVT.
Main Results:
- Reduced miR-128-3p expression promoted human umbilical vein endothelial cell (HUVEC) proliferation and migration while inhibiting inflammation, apoptosis, and adhesion.
- The effects of miR-128-3p on HUVECs were mediated through targeting SIRT1.
- miR-128-3p was found to be upregulated in patients with DVT and showed significant diagnostic capability.
Conclusions:
- Overexpression of miR-128-3p plays a role in DVT development.
- miR-128-3p demonstrates potential as a diagnostic biomarker for DVT patients.
Related Concept Videos
Venous Thrombosis I: Introduction
MicroRNAs
Venous Thrombosis III: Interprofessional Care
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

